Publication | Closed Access
Rifaximin Improves Psychometric Performance and Health-Related Quality of Life in Patients With Minimal Hepatic Encephalopathy (The RIME Trial)
241
Citations
35
References
2010
Year
Rifaximin significantly improves both cognitive functions and HRQOL in patients with MHE.
| Year | Citations | |
|---|---|---|
Page 1
Page 1